NCT04512144Recruiting
Mindfulness in Endometrial and Cervical Cancer
Mindfulness Practice in Endometrial and Cervical Cancers With Smartphone Applications (MECCA)
Source: ClinicalTrials.gov · Last updated 30 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Patients with endometrial cancer who will be undergoing surgery or patients with cervical cancer who will be treated with chemoradiation will be randomized to utilize the Headspace smartphone application or not prior to their anticipated treatment.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 26 Jul 2020
- Start date
- 25 Jul 2020
- Primary completion date
- 30 Jul 2026
- Lead sponsor
- St. Louis University
- Diseases
- Endometrial cancer, Cervical cancer
- NCT number
- NCT04512144
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 25 Jul 2020 to the primary completion date, 30 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Non-English speaking
- No access to smartphone
- Current use of Headspace application
Who the study is looking for
- New diagnosis of either 1) endometrial cancer undergoing surgery or 2) cervical cancer undergoing chemo-sensitizing radiation
- Access to a smartphone
Age in the registry: 18 years to 90 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Saint Louis University Coordinator of this site? Confirm its status | St Louis | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.